A Study to Assess the Safety and Efficacy of a Daily Disposable Contact Lens
Launched by BAUSCH & LOMB INCORPORATED · May 25, 2010
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects must have clear central corneas and be free of any anterior segment disorders.
- • Subjects must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
- • Subjects must be correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or better (distance, high contrast) in each eye.
- • Subjects must be of Asian descent.
- • Subjects must require plano or myopic correction and must require contact lens correction from plano to -6.00 D in both eyes.
- Exclusion Criteria:
- • Subjects who have any systemic disease affecting ocular health.
- • Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
- • Subjects with an active ocular disease or are using any ocular medication.
- • Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
- • Subjects with any scar or neovascularization within the central 4 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.
- • Subjects who currently wear monovision, multifocal, or toric contact lenses.
- • Subjects who are adapted wearers of 1-Day Acuvue Define daily disposable cosmetic tint contact lenses.
About Bausch & Lomb Incorporated
Bausch & Lomb Incorporated is a leading global eye health company dedicated to advancing the vision and well-being of individuals through innovative products and solutions. With a rich history spanning over 160 years, Bausch & Lomb specializes in the development, manufacturing, and marketing of a comprehensive range of eye care products, including contact lenses, lens care solutions, and pharmaceuticals for various ocular conditions. The company is committed to rigorous clinical research and trials to ensure the safety and efficacy of its offerings, striving to enhance patient outcomes and improve quality of life for those with vision-related challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, New York, United States
Patients applied
Trial Officials
Bev Barna
Study Director
Bausch & Lomb Incorporated
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials